These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7423200)
21. Recombinant DNA techniques in the pharmaceutical industry. Winther MD Med Lab Sci; 1985 Oct; 42(4):388-92. PubMed ID: 3866135 [No Abstract] [Full Text] [Related]
22. How Genentech Novartis stifled a promising drug: biotech firm tried to pursue a peanut allergy inject, but contract got in way; Zach avoids a "kiss of death". Hamilton DP Wall St J (East Ed); 2005 Apr; ():A1, A10. PubMed ID: 15926244 [No Abstract] [Full Text] [Related]
23. Perspectives. CMS and Wall Street report... Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066 [No Abstract] [Full Text] [Related]
24. Human insulin from recombinant DNA technology. Johnson IS Science; 1983 Feb; 219(4585):632-7. PubMed ID: 6337396 [TBL] [Abstract][Full Text] [Related]
25. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8(5):528-535 (November 1990). Horton RM; Cai Z; Ho SM; Pease LR Biotechniques; 2013 Mar; 54(3):129-33. PubMed ID: 23599925 [No Abstract] [Full Text] [Related]
26. Problems over TPA patent for Genentech in Japan. Swinbanks D Nature; 1988 Jun; 333(6174):587. PubMed ID: 3131683 [No Abstract] [Full Text] [Related]
27. Applications of recombinant DNA technology. Wetzel R Am Sci; 1980; 68(6):664-75. PubMed ID: 7224330 [No Abstract] [Full Text] [Related]
29. Increased efficiency of cloning large DNA fragments using a lower copy number plasmid. Feng T; Li Z; Jiang W; Breyer B; Zhou L; Cheng H; Haydon RC; Ishikawa A; Joudeh MA; He TC Biotechniques; 2002 May; 32(5):992, 994, 996 passim. PubMed ID: 12019795 [No Abstract] [Full Text] [Related]
30. Gene patenting and medical research: a view from a pharmaceutical company. Stott M; Valentine J Nat Rev Drug Discov; 2004 Apr; 3(4):364-8. PubMed ID: 15060532 [No Abstract] [Full Text] [Related]
31. Are there any good experiments that should not be done? Pollack R; Cobb M PLoS Biol; 2022 Feb; 20(2):e3001539. PubMed ID: 35157696 [TBL] [Abstract][Full Text] [Related]
32. Drug company merger should benefit research. Labreque G BMJ; 1998 Feb; 316(7130):494. PubMed ID: 9501704 [No Abstract] [Full Text] [Related]
33. How Genentech got it. Stipp D Fortune; 2003 Jun; 147(11):81-2, 84, 86 passim. PubMed ID: 12800575 [No Abstract] [Full Text] [Related]
35. Principles of DNA cloning. Miles JS; Wolf CR BMJ; 1989 Oct; 299(6706):1019-22. PubMed ID: 2556195 [No Abstract] [Full Text] [Related]
36. Molecular cloning using the interrupted recognition sequence of BplI to select for recombinant molecules. Mastrodicasa MA; Brandl CJ Biotechniques; 2002 Nov; 33(5):992, 994, 996. PubMed ID: 12449373 [No Abstract] [Full Text] [Related]
37. The use of directed ligation for obtaining high yields of recombinant DNA and for efficient transcloning. Briestanská J; Svoboda J Biotechniques; 1993 Aug; 15(2):220-2. PubMed ID: 8373582 [No Abstract] [Full Text] [Related]
38. Drug company 'suppressed' publication of research. Wadman M Nature; 1996 May; 381(6577):4. PubMed ID: 8609985 [No Abstract] [Full Text] [Related]
39. From the National Institute of Allergy and Infectious Diseases. Report on a workshop on DNA recombinant technology in interferon cloning. Dunnick JK; Merigan TC; Galasso GJ J Infect Dis; 1981 Feb; 143(2):297-300. PubMed ID: 6163831 [No Abstract] [Full Text] [Related]
40. [Cloning of the fish (Oncorhynchus keta) insulin gene in Escherichia coli]. Dem'ianova NG; Zlochevskiĭ ML; Kavsan VM; Kozlov IuI; Petrenko AI Dokl Akad Nauk SSSR; 1981; 256(4):999-1003. PubMed ID: 7014157 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]